Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ABBOTT LABORATORIES

(ABT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Abbott Laboratories : Gets Emergency Authorization for Serology Test

10/12/2020 | 09:28am EDT

By Matt Grossman

Abbott Laboratories has received an emergency-use authorization from the Food and Drug Administration for a test to detect antibodies for the new coronavirus, the company said Monday.

The lab-based test detects IgM antibodies, using Abbott's Architect and Alinity platforms. Antibody tests can be used to determine if someone has had a recent or prior infection with SARS-CoV-2, the virus that causes Covid-19.

Abbott said that the test will compliment the company's already-developed test for IgG antibodies. IgG testing is better suited to determining whether someone has been infected in the longer term, while IgM testing is most useful for detecting whether someone has had a recent infection, Abbott said.

Write to Matt Grossman at matt.grossman@wsj.com

(END) Dow Jones Newswires

10-12-20 0927ET

All news about ABBOTT LABORATORIES
07/29NEW STUDY : Half of Americans Living with Diabetes May be Consuming Less Than th..
PR
07/27Global markets live: LVMH, Michelin, Tesla, Amazon, Activision...
07/23ABBOTT LABORATORIES : Jefferies & Co Adjusts Abbott Laboratories PT to $135 From..
MT
07/23ABBOTT LABORATORIES : JPMorgan Adjusts Abbott Laboratories PT to $135 From $122,..
MT
07/23ABBOTT LABORATORIES : Morgan Stanley Adjusts Abbott Laboratories PT to $136 From..
MT
07/23ABBOTT LABORATORIES : Raymond James Adjusts Price Target on Abbott Laboratories ..
MT
07/23ABBOTT LABORATORIES : Credit Suisse Raises Abbott Laboratories' PT to $130 from ..
MT
07/23ABBOTT LABORATORIES : UBS Adjusts Abbott Laboratories' PT to $131 From $127, Cit..
MT
07/23ANALYST RECOMMENDATIONS : Apple, Aviva, Biogen, Comerica Incorporated, Tesla...
07/22GLOBAL MARKETS LIVE : AT&T, American Airlines, Biogen, Netflix, ABB...
More news
Financials (USD)
Sales 2021 39 766 M - -
Net income 2021 5 967 M - -
Net Debt 2021 8 719 M - -
P/E ratio 2021 36,1x
Yield 2021 1,41%
Capitalization 215 B 215 B -
EV / Sales 2021 5,63x
EV / Sales 2022 5,59x
Nbr of Employees 109 000
Free-Float 89,0%
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | MarketScreener
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Last Close Price 121,09 $
Average target price 128,81 $
Spread / Average Target 6,38%
EPS Revisions
Managers and Directors
Robert B. Ford President, CEO, Chief Operating Officer & Director
Robert Emmett Funck Chief Financial Officer & Executive Vice President
Miles D. White Executive Chairman
Sabina Ewing Chief Investment Officer, VP-Business & Technology
Roxanne Schuh Austin Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ABBOTT LABORATORIES10.07%215 155
MEDTRONIC PLC11.42%175 406
BECTON, DICKINSON AND COMPANY2.03%73 717
SARTORIUS STEDIM BIOTECH62.09%51 173
HOYA CORPORATION8.86%50 531
ALIGN TECHNOLOGY, INC.26.69%49 213